Trials / Conditions / Metastatic Urethral Carcinoma
Metastatic Urethral Carcinoma
3 registered clinical trials studyying Metastatic Urethral Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or NCT04940299 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted NCT03866382 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or C NCT02178241 | National Cancer Institute (NCI) | Phase 2 |